Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Asia Deal Watch: Simcere, G1 Partner Globally On Myelopreservation Drug

Aug 04 2020

• By Joseph Haas and Ian Haydock

Asia Deal Watch

Related Content

Teva Shifts Strategy In Japan

Jul 30 2020

New Drug Bonanza as Chi-Med, Eisai, Alexion Harvest Big Wins In China

Sep 07 2018

Oncology Deal-Making The Daiichi Way

Jul 28 2020

AZ Bets Big On ADCs As It Inks Second, $6bn Deal With Daiichi

Jul 27 2020

EQRx Reveals Two New Assets For Low-Cost Drug Pipeline

Jul 24 2020

Chi-Med Extends Oncology Commercial Reach To Realize China Potential

Jul 31 2020

Related Companies

Simcere Pharmaceutical Group

G1 Therapeutics Inc.

RVL Pharmaceuticals plc

Santen Pharmaceutical Co., Ltd.

HUTCHMED (China) Limited

Eli Lilly and Company

Harbour BioMed

Viva Biotech (Shanghai)

Schrodinger, Inc.

Otonomy, Inc.

Kyorin Pharmaceutical Co., Ltd.

Terns Pharmaceuticals, Inc.

IACTA Pharmaceuticals, Inc.

Zhaoke Pharmaceutical Limited

Additional Topics

Asia Pacific Deals Business Strategies M & A Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window